From fringe to federal: The rise of eugenicist thinking in US policy
By Donald Earl Collins,
Al Jazeera
| 05. 23. 2025
“The picture of the world’s richest man killing the world’s poorest children is not a pretty one,” Microsoft founder and billionaire philanthropist Bill Gates said of Elon Musk during an interview with The Financial Times earlier this month. Gates indirectly referenced Musk’s role in gutting the federal agency United States Aid for International Development (USAID), where billions of dollars had gone towards global poverty reduction and the eradication of diseases for decades. That is, until Musk led the charge for President Donald Trump’s unofficial Department of Government Efficiency (DOGE) to dismantle USAID in February. “And unless we reverse pretty quickly, that’ll be over a million additional deaths” of children worldwide, Gates said in an interview on The Late Show with Stephen Colbert, expanding on his Financial Times comments.
Despite what Gates and others may think, Musk’s disdain for human lives isn’t limited to his role in leading DOGE. Nor is this just Musk’s thinking. Trump has deployed in his administration and in his relationships with billionaires a group of the old and new eugenicists. Some of these leading men believe...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...